Testing effectiveness (Phase 2)UnknownNCT06183814What this trial is testingEXG102-031 in Participants With wAMDWho this might be right forNeovascular Age-related Macular Degeneration Guangzhou Jiayin Biotech Ltd 42
Not applicableStudy completedNCT07744984What this trial is testingThe Efficacy of Home OCT Supported Management in Patients Diagnosed With Neovascular-AMD and Undergoing a Drug Switch to FaricimabWho this might be right forAge-Related Macular Degeneration (AMD)Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD Rabin Medical Center 12
Not applicableLooking for participantsNCT06893965What this trial is testingAcute Intra Ocular Pressure Monitoring After Aflibercept 8mg/0.07mLWho this might be right forMacular Diseases Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer 100
Early research (Phase 1)WithdrawnNCT02450981What this trial is testingEvaluation the Pharmacokinetics, Safety, Tolerability of BCD-021 in Patients With Neovascular Age-related Macular DegenerationWho this might be right forNeovascular Age-related Macular Degeneration Biocad
Large-scale testing (Phase 3)Study completedNCT00090623What this trial is testingRhuFab V2 (Ranibizumab) in Subjects With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)Who this might be right forMacular Degeneration Genentech, Inc. 180
Not applicableStudy completedNCT03438669What this trial is testingCorrelation Between Visual Acuity Measurements, Quality of Life and Morphological Parameters in Wet AMD PatientsWho this might be right forMacular Degeneration Dr. med. Katja Hatz 53
Testing effectiveness (Phase 2)Study completedNCT00259753What this trial is testingSafety and Efficacy Study of Small Interfering Ribonucleic Acid (RNA) Molecule (Cand5) to Treat Wet Age-Related Macular DegenerationWho this might be right forMacular Degeneration OPKO Health, Inc. 120
Large-scale testing (Phase 3)UnknownNCT04113538What this trial is testingTreat and Extend Analysis Trial With Aflibercept in Wet-AMDWho this might be right forWet Age-related Macular Degeneration Michel Giunta 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06550011What this trial is testingClinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Intravitreal (IVT) Injection of ABI-110 (AAV2.N54-VEGF Trap) in Subjects With Neovascular (Wet) Age-Related Macular Degeneration (wAMD), Including Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV)Who this might be right forNeovascular (Wet) AMD Avirmax Biopharma Inc 18
Early research (Phase 1)Study completedNCT02461771What this trial is testingAssessment of Safety, Tolerability and Pharmacokinetics of Intravitreal Pegcetacoplan (APL-2) for Patients With Wet AMDWho this might be right forNeovascular Age-Related Macular Degeneration Apellis Pharmaceuticals, Inc. 13
Large-scale testing (Phase 3)Study completedNCT04740671What this trial is testingCompare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMDWho this might be right forAge Related Macular Degeneration Shanghai Henlius Biotech 410
Testing effectiveness (Phase 2)Study completedNCT01157065What this trial is testingEvaluation of AL-78898A in Exudative Age-Related Macular DegenerationWho this might be right forExudative Age-Related Macular Degeneration Alcon Research 99
Testing effectiveness (Phase 2)Ended earlyNCT02418754What this trial is testingStudy of Intravitreal REGN2176-3 in Participants With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)Who this might be right forNeovascular Age-Related Macular Degeneration Regeneron Pharmaceuticals 505
Not applicableActive Not RecruitingNCT07390253What this trial is testingSwitch From 2mg Aflibercept to 8mg Aflibercept in Patients With Neovascular Age-related Macular DegenerationWho this might be right forNeovascular (Wet) Age-Related Macular Degeneration Vienna Institute for Research in Ocular Surgery 50
Large-scale testing (Phase 3)Study completedNCT00041483What this trial is testingPhase 3 Study to Evaluate Anecortave Acetate vs. Visudyne for the Treatment of the Wet Form of AMDWho this might be right forMacular Degeneration Alcon Research 530
Early research (Phase 1)Study completedNCT02204683What this trial is testingPharmacokinetic Study of Intravitreal Aflibercept Injection in Eyes With Wet Age-related Macular DegenerationWho this might be right forNeovascular Macular Degeneration University of Nebraska 5
Early research (Phase 1)Study completedNCT06969001What this trial is testingClinical Study for the Evaluation of Safety and Tolerability of SCAI-005 Eye DropsWho this might be right forWet Age Related Macular Degeneration SCAI Therapeutics 48